MARC details
000 -LEADER |
fixed length control field |
05096naaaa2201165uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/68946 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714160856.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-03943-039-0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039430383 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039430390 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-03943-039-0 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Cabral, Joaquim M. S. |
Relator code |
edt |
9 (RLIN) |
1571194 |
245 10 - TITLE STATEMENT |
Title |
Stem Cell Bioprocessing and Manufacturing |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel, Switzerland |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2020 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (170 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
The next healthcare revolution will apply regenerative medicines using human cells and tissues. The aim of the regenerative medicine approach is to create biological therapies or substitutes in vitro for the replacement or restoration of tissue function in vivo lost through failure or disease. However, whilst science has revealed the potential, and early products have shown the power of such therapies, there is an immediate and long-term need for expertise with the necessary skills to face the engineering and life science challenges before the predicted benefits in human healthcare can be realized. Specifically, there is a need for the development of bioprocess technology for the successful transfer of laboratory-based practice of stem cell and tissue culture to the clinic as therapeutics through the application of engineering principles and practices. This Special Issue of Bioengineering on Stem Cell Bioprocessing and Manufacturing addresses the central role in defining the engineering sciences of cell-based therapies, by bringing together contributions from worldwide experts on stem cell biology and engineering, bioreactor design and bioprocess development, scale-up, and manufacturing of stem cell-based therapies. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
electrospinning |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
live-cell electrospinning |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tissue engineering |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell seeding |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
high voltage |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
viability |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
allogeneic cell therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
induced pluripotent stem cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
human embryonic stem cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell aggregate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
expansion |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
differentiation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
scalable manufacturing |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
scale up |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
single-use bioreactor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Vertical-Wheel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
U-shaped vessel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
computational fluid dynamics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
shear stress |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
turbulent energy dissipation rates |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
homogeneous hydrodynamic environment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
human pluripotent stem cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hepatic cell lineages |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hepatocyte differentiation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
non-parenchymal liver cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
liver organoids |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
disease modeling |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
drug screening |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
olfactory ensheathing cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
spinal cord injury |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
neural regeneration |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell therapies |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
adipose stem cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
neurotrophic factors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
growth factors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
peripheral nerve injuries |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
fibrin nerve conduits |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrogels |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
stem cells delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
axonal regeneration |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Schwann cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
stromal vascular fraction |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
stem cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
adipose-derived stem cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
infrapatellar fat pad |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
knee |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
arthroscopy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
arthrotomy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bioreactor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hMSCs |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microcarrier |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bioprocess |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
embryonic stem cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mesenchymal stromal cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
blood platelets |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell culture techniques |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
progenitor cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
human adipose stem cells (hASCs) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
serum- and xeno-free conditions |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
UrSuppe stem cell culture medium |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
autologous therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
kinetic growth modeling |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
segregated and unstructured growth model |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
model predictive control |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bio-process |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell growth |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lactate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
advanced therapy medicinal products |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lobato da Silva, Cláudia |
Relator code |
edt |
9 (RLIN) |
1571195 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Diogo, Maria Margarida |
Relator code |
edt |
9 (RLIN) |
1571196 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Cabral, Joaquim M. S. |
Relator code |
oth |
9 (RLIN) |
1571194 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lobato da Silva, Cláudia |
Relator code |
oth |
9 (RLIN) |
1571195 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Diogo, Maria Margarida |
Relator code |
oth |
9 (RLIN) |
1571196 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/2713">https://mdpi.com/books/pdfview/book/2713</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68946">https://directory.doabooks.org/handle/20.500.12854/68946</a> |
-- |
0 |
Public note |
DOAB: description of the publication |